Emily Parker @911GlobalMeds
06 March, 03:44
The Effectiveness of Brigatinib over Crizotinib for Treating Non-Small Cell Lung Cancer

Brigatinib / Alunbrig is a cancer medication belonging to the class of anaplastic lymphoma kinase inhibitor or ALK. It has been proven to be efficient in treating non-small cell lung cancer or NSCLC that is ALK positive.

The ALK gene occurs in only 3-5 % of the patients of NSCLC. Crizotinib (also a first generation ALK inhibitor) showed a longer progression-free survival when compared to platinum based double agent chemotherapy medication.

Source: https://shorturl.at/bilG6

#BrigatinibSuccess #NSCLC #LungCancerTreatment #BrigatinibVsCrizotinib #MedicalAdvancements #cancerresearch #TargetedTherapy #PrecisionMedicine #lungcancerawareness #fightagainstcancer #TreatmentBreakthroughs #HealthcareInnovation #SurvivorStories #PersonalizedMedicine #clinicaltrials #BetterOutcomes #ImprovingSurvivalRates #InnovativeMedicine #ProgressInOncology #MedicalBreakthroughs #HopeForPatients #NSCLCTreatment

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Emily Parker @911GlobalMeds
26 February, 05:00
Breast cancer treatment by Everolimus Therapy

Everolimus along with exemestane was approved for treating HER2 negative and HR-positive metastatic breast cancer after anastrozole or letrozole treatment had not shown successful. The results of this study showed that progression free survival was 4 months more for everolimus + exemestane treatment. The median PFS for exemestane + placebo group was 2.8 months as compares to everolimus + exemestane's 6.9 months.

Source: https://shorturl.at/fmCJ7

#EverolimusTherapy #BreastCancerTreatment #cancerresearch #MedicalInnovation #HealthcareAdvances #fightagainstcancer #WomenHealth #MedicalBreakthrough #Oncology #treatmentoptions #CancerTherapy

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Emily Parker @911GlobalMeds
23 February, 02:52
Survival Improvements in Ovarian Cancer by using Sorafenib

According to a new study, topotecan and Nexavar (generic Sorafenib) when combined, and there after used as a maintenance therapy has significantly improve the survival outcomes in women who are suffering from platinum-resistant ovarian cancer.

Source: https://shorturl.at/eiCDL

#OvarianCancerSurvival
#SorafenibTreatment
#cancerresearch
#SurvivalImprovements
#ovariancancerawareness
#MedicalAdvancements
#TreatmentInnovation
#fightagainstcancer
#HealthcareBreakthroughs
#cancersurvivor

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Emily Parker @911GlobalMeds
20 February, 06:23
How Imatinib (Gleevec) Transformed Leukemia Treatment and Cancer Research

Gleevec (Imatinib) was developed with primarily with the help of researches conducted by National Cancer Institute (NCI), and Imatinib was one of the discoveries they made. This Drug has drastically improved the outcomes of patients who were suffering from Blood Cancer primarily Chronic Myelogenous Leukaemia. And due to the discoveries made by NCI that lead to Imatinib, they helped to establish a Targeted Therapy which had revolutionised the field of Cancer Research.

See full Article: https://shorturl.at/tyIL7

#Imatinib #Gleevec #LeukemiaTreatment #cancerresearch #MedicalBreakthrough
#TargetedTherapy #fightagainstcancer #InnovationInMedicine #HopeForPatients #TransformativeTreatment #ResearchAdvancements
#LifeSavingMedication #HealthCareHeroes #ScienceProgress #CancerAwareness #MedicalInnovation

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Emily Parker @911GlobalMeds
19 February, 12:41
The Effects of Gefitinib in EGFR Mutation Breast Cancer

Researchers have explored this treatment concept that iressa / gefitinib in combination with fulvestrant (an estrogen receptor antagonist) can have a positive impact on the hormonal therapy's anti-tumour effect.

Source: https://shorturl.at/bcsvH

#Gefitinib
#BreastCancer
#cancertreatment
#TargetedTherapy
#EGFRInhibitor
#cancerresearch
#Oncology
#HealthCare
#medicalscience
#SurvivorStories
#breastcancerawareness
#fightagainstcancer
#HopeForACure
#treatmentoptions
#PrecisionMedicine
#ChemotherapyAlternative
#TherapeuticAdvancements
#clinicaltrials
#SupportiveCare
#empowerment

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396

Nothing found!

Sorry, but we could not find anything in our database for your search query {{search_query}}. Please try again by typing other keywords.